NCT00432770View on ClinicalTrials.gov

Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

December 31, 2006

Study Completion Date

March 31, 2007

Conditions
Thrombosis
Interventions
DRUG

ARC1779

Trial Locations (1)

21201

Bioanalytical Systems, Inc, Baltimore

Sponsors

Lead Sponsor

Archemix Corp.
All Listed Sponsors
lead

Archemix Corp.

INDUSTRY

NCT00432770 - Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 in Healthy Volunteers | Biotech Hunter | Biotech Hunter